Presentations.ai AI Slide Generator Automates Investor Pitch Decks and Sales PPTs for 12 Million Users – The AI PowerPoint Maker Scales Professional Slide Generation With Branding, Design and Data CRISPR Therapeutics Announces Poster Presentation at the American Association for Cancer Research 2022 Annual Meeting
ZUG, Switzerland and CAMBRIDGE, Mass., March 08, 2022 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP),…
Affimed Announces Clinical Updates at the Annual Meeting of the American Association for Cancer Research
In a Clinical Trials Plenary Session an update of the phase 1/2 study evaluating cord…
Sana Biotechnology to Present Preclinical Data on its Engineered Hypoimmune Allogeneic CAR T Cells at the 2022 American Association for Cancer Research Annual Meeting
SEATTLE, March 08, 2022 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused…
Iovance Biotherapeutics to Present at American Association for Cancer Research (AACR) 2022 Annual Meeting
SAN CARLOS, Calif., March 08, 2022 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a…
Theratechnologies to Present Three Posters at AACR Including New In Vivo TH1902 Preclinical Data Demonstrating Tumor Growth Inhibition of Human Cancer Stem-Like Cells (CD133+) in Both Triple-Negative Breast and Ovarian Cancers
MONTREAL, March 08, 2022 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or “the Company”) (TSX: TH)…
Erasca Announces Six Poster Presentations at the 2022 AACR Annual Meeting
Posters will feature programs with best-in-class potential including ERK1/2 inhibitor ERAS-007, SHP2 inhibitor ERAS-601, and…
Bolt Biotherapeutics to Present Updates for Three Preclinical Immuno-Oncology Pipeline Programs at AACR Annual Meeting 2022
REDWOOD CITY, Calif., March 08, 2022 (GLOBE NEWSWIRE) — Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage…
Rubius Therapeutics to Present Updated Results from Single-Agent Phase 1 Clinical Trial of RTX-240 at the American Association of Cancer Research Annual Meeting
Updated Results from Single-Agent Phase 1 Clinical Trial of RTX-240 in Advanced Solid Tumors to…
Bio-Path Holdings to Present at the 2022 American Association for Cancer Research Annual Meeting
HOUSTON, March 08, 2022 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company…
Nykode Therapeutics to Present at 2022 American Association for Cancer Research (AACR) Annual Meeting
OSLO, Norway, March 08, 2022 (GLOBE NEWSWIRE) — Nykode Therapeutics AS (Euronext Growth (Oslo): NYKD),…
Tempest to Present Two Posters at the 2022 American Association for Cancer Research (AACR) Annual Meeting
SOUTH SAN FRANCISCO, Calif., March 08, 2022 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST),…
TCR² Therapeutics to Highlight Off-the-Shelf TRuC-T Cell at the American Association of Cancer Research Annual Meeting 2022
CAMBRIDGE, Mass., March 08, 2022 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage…
Checkmate Pharmaceuticals to Present at the 2022 American Association for Cancer Research (AACR) Annual Meeting
CAMBRIDGE, Mass., March 08, 2022 (GLOBE NEWSWIRE) — Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) (“Checkmate”), a clinical stage biotechnology company…
IO Biotech Announces Acceptance of Abstract to be Presented at AACR Annual Meeting on April 8, 2022
Clinical Update from Phase 1/2 study of IO102-IO103 in Combination with Nivolumab in Metastatic Melanoma…
ORIC Pharmaceuticals Announces Multiple Presentations at the 2022 American Association for Cancer Research (AACR) Annual Meeting
ORIC-533 oral presentation and poster presentation to highlight potential of small molecule inhibitor of CD73…
Zentalis Pharmaceuticals to Present New Clinical and Preclinical Data at the AACR Annual Meeting 2022
Updated data from Phase 1 expansion cohort of ZN-c3 in uterine serous carcinoma (USC) will…
Senti Bio to Present Preclinical Data on Cancer-Killing Allogeneic CAR-NK Cells at AACR Annual Meeting
– Abstract highlights the Company’s progress in applying gene circuits to improve the cytotoxicity and…
C4 Therapeutics to Present at the American Association for Cancer Research (AACR) Annual Meeting 2022
– Clinical Data from Cohort A of the Ongoing Phase 1/2 Trial of CFT7455, a…
Statera Biopharma Announces Revised Preliminary Revenue and Financial Results of Fiscal Year 2021
FORT COLLINS, Colo., March 08, 2022 (GLOBE NEWSWIRE) — Statera Biopharma, Inc. (NASDAQ: STAB) (the…
NGM Bio Announces Oral and Late-Breaking Poster Presentations Supporting Its Myeloid Reprogramming Portfolio at Upcoming 2022 AACR Annual Meeting
Oral presentation to showcase NGM Bio’s in vitro and in vivo research demonstrating potential advantages…